Trial Profile

The Cubicin Outcomes Registry and Experience (CORE), a retrospective observational record review of patients with serious Gram-positive infections treated with daptomycin in the real-world setting at 70 separate institutions in the United States from January 2005 through December 2009.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 18 May 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

12 Apr 2016 Results of pooled analysis of CORE and EU-CORE registries (n=11557) presented at the 26th European Congress of Clinical Microbiology and Infectious Diseases
26 Nov 2015 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com